Current role
Biotechnology · Healthcare
Board Member
2026-10-23–present
Rob Scott, MD
Board Member
Arcutis Biotherapeutics, Inc. (ARQT)Equibles does not estimate personal net worth.
Get an email with a short summary when Arcutis Biotherapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ARQT alertsAbout Rob Scott, MD
Rob Scott, MD is recorded as Board Member at Arcutis Biotherapeutics, Inc. (ARQT) since October 23, 2026. Arcutis Biotherapeutics, Inc. reported in an 8-K filed October 28, 2026 that Rob Scott, MD was appointed Arcutis Board of Directors, effective October 23, 2026. Arcutis Biotherapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Arcutis Biotherapeutics, Inc. includes Todd Franklin Watanabe (CEO and Board Member), Latha Vairavan (CFO), Masaru Matsuda (General Counsel) and 7 others.
“Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovation in immuno-dermatology, today announced that Rob Scott, MD has been appointed to the Arcutis Board of Directors effective October 23, 2026.”
Affiliation history
-
Current
2026-10-23–present
Company network
Leadership on record at Arcutis Biotherapeutics, Inc.
- Todd Franklin Watanabe CEO, Board Member
- Latha Vairavan CFO
- Masaru Matsuda General Counsel
- David Topper Chief Accounting Officer
- Scott Burrows Chief Accounting Officer
- Amit D. Munshi Board Member
- Chris Peetz Board Member
- Christopher Peetz Board Member
- Halley E. Gilbert Board Member
- Howard G. Welgus Board Member